Mounjaro

Active Ingredient(s): Tirzepatide
FDA Approved: * May 13, 2022
Pharm Company: * ELI LILLY CO
Category: Diabetes
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mounjaro 15 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1457

Labeler:

Eli Lilly and Company

Mounjaro 12.5 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1460

Labeler:

Eli Lilly and Company

Mounjaro 10 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1471

Labeler:

Eli Lilly and Company

Mounjaro 7.5 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1484

Labeler:

Eli Lilly and Company

Mounjaro 5 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1495

Labeler:

Eli Lilly and Company

Mounjaro 2.5 mg/.5ml Subcutaneous Injection, Solution

NDC: 0002-1506

Labeler:

Eli Lilly and Company